Holen Sie sich die Stockscreener-App
1.65
4.07%
-0.07
Handel nachbörslich:
1.65
Schlusskurs vom Vortag:
$1.72
Offen:
$1.69
24-Stunden-Volumen:
357.08K
Relative Volume:
0.40
Marktkapitalisierung:
$104.29M
Einnahmen:
$139.77M
Nettoeinkommen (Verlust:
$-97.62M
KGV:
-1.0443
EPS:
-1.58
Netto-Cashflow:
$-61.71M
1W Leistung:
-4.62%
1M Leistung:
+0.61%
6M Leistung:
-7.82%
1J Leistung:
-45.72%
1-Tages-Spanne:
$1.63
$1.69
1-Wochen-Bereich:
$1.58
$1.82
52-Wochen-Spanne:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
Firmenname
Macrogenics Inc
Sektor
Branche
Telefon
301-251-5172
Adresse
9704 MEDICAL CENTER DRIVE, Rockville, MD
Vergleichen Sie MGNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.65 | 108.71M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Fortgesetzt | Barclays | Overweight |
| 2024-11-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-07-31 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-05-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-04-26 | Eingeleitet | B. Riley Securities | Buy |
| 2024-04-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-03-04 | Bestätigt | BTIG Research | Buy |
| 2024-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-11-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-11-22 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-11-14 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-02-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-04 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-11-17 | Fortgesetzt | Guggenheim | Buy |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Hochstufung | Barclays | Underweight → Overweight |
| 2020-12-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2019-12-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-11-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2019-04-12 | Eingeleitet | Guggenheim | Neutral |
| 2019-02-07 | Hochstufung | Citigroup | Sell → Buy |
| 2019-02-07 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-02-06 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-12-10 | Herabstufung | Raymond James | Outperform → Underperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-31 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Macrogenics Inc Aktie (MGNX) Neueste Nachrichten
Intraday pattern recognizer results for MacroGenics Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Statistical indicators supporting MacroGenics Inc.’s strengthIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
Using data models to predict MacroGenics Inc. stock movementJuly 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com
Backtesting results for MacroGenics Inc. trading strategiesTrade Risk Summary & Technical Pattern Alert System - newser.com
Published on: 2025-09-22 05:42:18 - newser.com
Barclays Upgrades MacroGenics (NASDAQ:MGNX) to "Strong-Buy" - MarketBeat
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - MarketBeat
Acadian Asset Management LLC Grows Position in MacroGenics, Inc. $MGNX - MarketBeat
Live market analysis of MacroGenics Inc.Quarterly Market Summary & Safe Capital Allocation Plans - newser.com
What institutional flow reveals about MacroGenics Inc.July 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Multi asset correlation models including MacroGenics Inc.Earnings Recap Report & Consistent Return Strategy Ideas - newser.com
Momentum divergence signals in MacroGenics Inc. chartProfit Target & Weekly Market Pulse Alerts - newser.com
What indicators show strength in MacroGenics Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
Using economic indicators to assess MacroGenics Inc. potential2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
MacroGenics Inc. stock trend outlook and recovery pathDay Trade & Daily Technical Stock Forecast Reports - newser.com
Growth Recap: Will MacroGenics Inc outperform the market in YEARJuly 2025 Sentiment & Fast Entry High Yield Tips - خودرو بانک
Macro Review: Why is Alpha Modus Holdings Inc Equity Warrant stock going upEarnings Trend Report & Smart Money Movement Tracker - khodrobank.com
MacroGenics Inc. recovery potential after sell off2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Quarterly Earnings: What is MacroGenics Inc.’s market positionJuly 2025 Movers & Weekly High Conviction Trade Ideas - khodrobank.com
Insider Buy: What makes MacroGenics Inc stock attractive todayTrade Entry Summary & Reliable Price Breakout Signals - خودرو بانک
MGNX Stock: Barclays Assumes Overweight Rating with $3 Price Tar - GuruFocus
How sentiment analysis helps forecast MacroGenics Inc.IPO Watch & Entry Point Strategy Guides - newser.com
MacroGenics, Inc. (NASDAQ:MGNX) Receives $3.60 Consensus Price Target from Brokerages - MarketBeat
Visualizing MacroGenics Inc. stock with heatmapsEarnings Risk Report & Fast Gain Swing Alerts - newser.com
Volatility clustering patterns for MacroGenics Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com
MacroGenics assumed with an Overweight at Barclays - TipRanks
Buy Signal: What is the next catalyst for MacroGenics IncBuy Signal & Weekly High Potential Stock Alerts - خودرو بانک
Macro Review: Is HCSG stock a falling knife or bargain buyPortfolio Update Report & Expert Verified Stock Movement Alerts - khodrobank.com
Fed Watch: Is reAlpha Tech Corp. a turnaround storyJuly 2025 Setups & Advanced Technical Analysis Signals - خودرو بانک
Downgrade Watch: What is MacroGenics Inc. s 5 year growth outlook2025 Growth vs Value & Trade Opportunity Analysis - خودرو بانک
Hedge Fund Bets: Can MacroGenics Inc. grow without dilutionMarket Risk Analysis & Reliable Price Breakout Alerts - خودرو بانک
Investment Report: Can LFUS lead its sector in growthMarket Growth Report & High Accuracy Investment Signals - خودرو بانک
Stock Analysis: Can MacroGenics Inc. reach all time highs this yearChart Signals & Precise Swing Trade Entry Alerts - خودرو بانک
Sentiment Review: What makes MacroGenics Inc stock attractive todayTrade Entry Report & Long-Term Safe Investment Ideas - خودرو بانک
Fund Flows: Can MacroGenics Inc be the next market leaderJuly 2025 Drop Watch & Accurate Buy Signal Notifications - خودرو بانک
Take Profit: Is MacroGenics Inc. stock forming a triangle patternJuly 2025 PostEarnings & Entry Point Strategy Guides - خودرو بانک
Analyst Calls: What is MacroGenics Inc. s 5 year growth outlook2025 Sector Review & Verified Momentum Stock Alerts - خودرو بانک
Nuveen LLC Purchases Shares of 198,470 MacroGenics, Inc. $MGNX - MarketBeat
Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Cuts Target Price to $4 - 富途牛牛
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances By Investing.com - Investing.com South Africa
MacroGenics at H.C. Wainwright Conference: Strategic Antibody Advances - Investing.com India
Published on: 2025-09-08 14:52:02 - beatles.ru
MacroGenics Inc. Flashes Buy Signal on Multi Timeframe ChartJuly 2025 Earnings & Fast Entry Momentum Alerts - beatles.ru
Long term hold vs stop loss in MacroGenics Inc.Buy Signal & Accurate Buy Signal Notifications - Newser
Can MacroGenics Inc. reach all time highs this yearPortfolio Growth Summary & Technical Analysis for Trade Confirmation - خودرو بانک
What is MacroGenics Inc.’s market position2025 Growth vs Value & Short-Term Trading Alerts - خودرو بانک
What is the next catalyst for MacroGenics Inc.Portfolio Performance Summary & Real-Time Stock Price Movement Reports - خودرو بانک
Top chart patterns to watch in MacroGenics Inc.Weekly Profit Summary & Reliable Intraday Trade Alerts - Newser
Can MacroGenics Inc. stock double in the next yearEarnings Beat & Real-Time Volume Analysis - خودرو بانک
Will MacroGenics Inc. benefit from macro trendsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
MacroGenics' Strategic Divestitures and Implications for Biotech Innovation - AInvest
Finanzdaten der Macrogenics Inc-Aktie (MGNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):